Search
Search Results
Found 16 items.
-
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma
Published: 16 May 2024304PDF: 102 -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
Published: 16 May 2024262PDF: 143 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024400PDF: 171 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241228PDF: 205 -
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis
Published: 16 May 2024479PDF: 221 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024251PDF: 112 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024286PDF: 148 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024424PDF: 157 -
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Published: 16 May 2024907PDF: 170 -
Distal deep vein thrombosis: is there a way out of this dark forest?
Published: 4 September 2024390PDF: 117 -
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines
Published: 27 January 2023533PDF: 254 -
Welcome to the 12th ICTHIC!
Published: 16 May 20241238PDF: 160 -
Endothelial cell dysfunction in cancer: a not-so-innocent bystander
Published: 16 May 2024891PDF: 127 -
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review
Published: 16 May 2024275PDF: 101 -
Venous thromboembolism and mortality in patients with hematological malignancies
Published: 16 May 2024290PDF: 119 -
Oral Communications and Posters
Published: 16 May 2024236PDF: 257
1 - 16 of 16 items